切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2023, Vol. 17 ›› Issue (03) : 285 -289. doi: 10.11817/j.issn.1673-9248.2023.03.016

综述

脑卒中共病患者的共病现况及健康管理的研究进展
鄢嫣, 胡娴静, 张鹤立, 李葆华()   
  1. 100191 北京大学第三医院护理部
    100191 北京大学第三医院康复医学
  • 收稿日期:2022-08-29 出版日期:2023-06-01
  • 通信作者: 李葆华

Research progress on multimorbidity and health management of stroke patients with multiple chronic conditions

Yan Yan, Xianjing Hu, Heli Zhang, Baohua Li()   

  1. Department of Nursing, Peking University Third Hospital, Beijing 100191, China
    Department of Rehabilitation Medicine, Peking University Third Hospital, Beijing 100191, China
  • Received:2022-08-29 Published:2023-06-01
  • Corresponding author: Baohua Li
引用本文:

鄢嫣, 胡娴静, 张鹤立, 李葆华. 脑卒中共病患者的共病现况及健康管理的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 285-289.

Yan Yan, Xianjing Hu, Heli Zhang, Baohua Li. Research progress on multimorbidity and health management of stroke patients with multiple chronic conditions[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(03): 285-289.

随着人们生活方式的改变和人口老龄化的加剧,慢性病患者中共病现象也在逐渐增多。脑卒中后患者常伴随着不同程度的日常生活活动障碍,而共病现象又会增加脑卒中患者健康管理的复杂度,使脑卒中患者的健康状况更差、死亡危险性更高、预后更差、住院次数增多以及就医成本与健康管理服务资源使用水平的提高,因此,脑卒中共病成为社会各界和研究中所关心的重大健康问题。本文就国内外脑卒中共病患者的患病率、健康结局及其健康管理现况做出总结,旨在为更好地开展脑卒中共病患者的健康管理服务及实践提供依据。

Due to the change in people's lifestyle and the aggravation of population aging, the phenomenon of patients with multiple chronic conditions is also increasing gradually. Patients with stroke are often accompanied by disorders of activities of daily life in varying degrees, and the phenomenon of multimorbidity will increase the complexity of health management of stroke patients. As a result, stroke patients have worse health status, higher risk of death, worse prognosis, more hospitalization, higher cost of medical treatment and higher level of use of health management service resources. Therefore, it has increasingly become a major health issue of concern to all sectors of society and research institutes. This article will summarize the prevalence rate, health outcome, and health management status of stroke patients with multiple chronic conditions at home and abroad, to provide a basis for better health management services and practice of stroke patients with various chronic conditions.

1
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016 [J]. Lancet, 2017, 390(10100): 1151-1210.
2
Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013 [J]. Lancet, 2016, 387(10015): 251-272.
3
Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010 [J]. Lancet, 2014, 383(9913): 245-255.
4
Satariano WA, Boyd CM. Improving the evidence base on multimorbidities through better research: a commentary on the U.S. HHS initiative, multiple chronic conditions: a strategic framework [J]. J Comorb, 2013, 3(Spec Issue): 18-21.
5
Boersma P, Black LI, Ward BW. Prevalence of multiple chronic conditions among US adults, 2018 [J]. Prev Chronic Dis, 2020, 17: E106.
6
Palladino R, Tayu Lee J, Ashworth M, et al. Associations between multimorbidity, healthcare utilisation and health status: Evidence from 16 European countries [J]. Age Ageing, 2016, 45(3): 431-435.
7
闫伟, 路云, 张冉, 等. 基于CHARLS数据分析的我国老年人共病现状研究 [J]. 中华疾病控制杂志, 2019, 23(4): 426-430.
8
Gallacher K, Morrison D, Jani B, et al. Uncovering treatment burden as a key concept for stroke care: a systematic review of qualitative research [J]. PLoS Med, 2013, 10(6): e1001473.
9
Kingston A, Robinson L, Booth H, et al. Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model [J]. Age Ageing, 2018, 47(3): 374-380.
10
Johnston MC, Crilly M, Black C, et al. Defining and measuring multimorbidity: a systematic review of systematic reviews [J]. Eur J Public Health, 2019, 29(01): 182-189.
11
U.S. Department of Health and Human Services. Multiple chronic conditions-a strategic framework: optimum health and quality of life for individuals with multiple chronic conditions [R]. Washington (DC): US Department of Health and Human Services, 2010.
12
Yousufuddin M, Bartley AC, Alsawas M, et al. Impact of multiple chronic conditions in patients hospitalized with stroke and transient ischemic attack [J]. J Stroke Cerebrovasc Dis, 2017, 26(6): 1239-1248.
13
Gruneir A, Griffith LE, Fisher K, et al. Increasing comorbidity and health services utilization in older adults with prior stroke [J]. Neurology, 2016, 87(20): 2091-2098.
14
Gallacher KI, Batty GD, McLean G, et al. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden [J]. BMC Med, 2014, 12: 151.
15
Tran J, Norton R, Conrad N, et al. Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: a population-based cohort study [J]. PLoS Med, 2018, 15(3): e1002513.
16
曾利, 王仲言, 谷雨萌, 等. 社区老年脑卒中人群共病现况分析 [J]. 现代预防医学, 2021, 48(10): 1822-1825.
17
唐敏华, 催淑衡, 易康祺, 等. 上海市松江区社区脑卒中人群共病现况研究 [J]. 上海预防医学, 2022, 34(9): 888-894.
18
Ding R, Zhu D, Ma Y, et al. Comparison of health service use and costs in stroke with and without comorbidities: a cross-sectional analysis using China urban medical claims data [J]. BMJ Open, 2020, 10(12): e037032.
19
Schmidt M, Jacobsen JB, Johnsen SP, et al. Eighteen-year trends in stroke mortality and the prognostic influence of comorbidity [J]. Neurology, 2014, 82(4): 340-350
20
Boehme AK, Esenwa C, Elkind MS, et al. Stroke risk factors, genetics, and prevention [J]. Circ Res, 2017, 120(3): 472-495.
21
Peters SAE, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta- analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes [J]. Lancet, 2014, 383(9933): 1973-1980.
22
Sahathevan R, Brodtmann A, Donnan GA. Dementia, stroke, and vascular risk factors; a review [J]. Int J Stroke, 2012, 7(1): 61-73.
23
Schwab P, Dhamane AD, Hopson SD, et al. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population [J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 735-744.
24
Kallmünzer B, Breuer L, Kahl N, et al. Serious cardiac arrhythmias after stroke: incidence, time course, and predictors--a systematic, prospective analysis [J]. Stroke, 2012, 43(11): 2892-2897.
25
Forjaz MJ, Rodriguez-Blazquez C, Ayala A, et al. Chronic conditions, disability, and quality of life in older adults with multimorbidity in Spain [J]. Eur J Intern Med, 2015, 26(3): 176-181.
26
Eva HD, Vladimir C, Christine B, et al. Multiple chronic conditions and life expectancy: a life table analysis [J]. Med Care, 2014, 52(8): 688-694.
27
王姣锋, 王一倩, 保志军, 等. 上海地区中老年体检人群慢性病及共病流行病学分析 [J].老年医学与保健, 2016, 22(2): 116-120.
28
Goldstein LB, Samsa GP, Matchar DB, et al. Charlson index comorbidity adjustment for ischemic stroke outcome studies [J]. Stroke, 2004, 35(8): 1941-1945.
29
Zhu H, Hill MD. Stroke: the elixhauser index for comorbidity adjustment of in-hospital case fatality [J]. Neurology, 2008, 71(4): 283-287.
30
Bartoli F, Lillia N, Lax A, et al. Depression after stroke and risk of mortality: a systematic review and meta-analysis [J]. Stroke Res Treat, 2013, 2013: 862978.
31
Specogna AV, Turin TC, Patten SB, et al. Hospital treatment costs and length of stay associated with hypertension and multimorbidity after hemorrhagic stroke [J]. BMC Neurol, 2017, 17(1): 158.
32
Yue R, Li D, Yu J, et al. Atrial fibrillation is associated with poor outcomes in thrombolyzed patients with acute ischemic stroke: a systematic review and meta-analysis [J]. Medicine (Baltimore), 2016, 95(10): e3054.
33
Desilles JP, Meseguer E, Labreuche J, et al. Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review [J]. Stroke, 2013, 44(7): 1915-1923.
34
Kabboord AD, van Eijk M, Fiocco M, et al. Assessment of comorbidity burden and its association with functional rehabilitation outcome after stroke or hip fracture: a systematic review and meta-analysis [J]. J Am Med Dir Assoc, 2016, 17(11): 1066.e13-1066.e21.
35
刘玉华, 郭富强, 王建红, 等. 中老年急性缺血性脑卒中患者共病状态 与卒中后功能恢复的相关性研究 [J]. 中国全科医学, 2020, 23(4): 453-458.
36
Berlowitz DR, Hoenig H, Cowper DC, et al. Impact of comorbidities on stroke rehabilitation outcomes: does the method matter? [J]. Arch Phys Med Rehabil, 2008, 89(10): 1903-1906.
37
Denti L, Artoni A, Casella M, et al. Validity of the modified Charlson comorbidity index as predictor of short-term outcome in older stroke patients [J]. J Stroke Cerebrovasc Dis, 2015, 24(2): 330-336.
38
Koroukian SM, Warner DF, Owusu C, et al. Multimorbidity redefined: prospective health outcomes and the cumulative effect of co-occurring conditions [J]. Prev Chronic Dis, 2015, 12: E55.
39
Salisbury C, Man MS, Bower P, et al. Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach [J]. Lancet, 2018, 392(10141): 41-50.
40
Smith SM, Soubhi H, Fortin M, et al. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings [J]. Cochrane Database Syst Rev, 2012(4): CD006560
41
Nelson MLA, McKellar KA, Yi J, et al. Stroke rehabilitation evidence and comorbidity: a systematic scoping review of randomized controlled trials [J]. Top Stroke Rehabil, 2017, 24(5): 374-380.
42
Nelson ML, Grudniewicz A, Albadry S. Applying clinical practice guidelines to the complex patient: insights for practice and policy from stroke rehabilitation [J]. Healthc Q, 2016, 19(2): 38-43.
43
Gallacher KI, May CR, Langhorne P, et al. A conceptual model of treatment burden and patient capacity in stroke [J]. BMC Fam Pract, 2018, 19(1): 9.
44
Pindus DM, Mullis R, Lim L, et al. Stroke survivors' and informal caregivers' experiences of primary care and community healthcare services-a systematic review and meta-ethnography [J]. PloS One, 2018, 13(2): e0192533.
45
Jamison J, Graffy J, Mullis R, et al. Barriers to medication adherence for the secondary prevention of stroke: a qualitative interview study in primary care [J]. Br J Gen Pract, 2016, 66(649): e568-e576.
46
Shippee ND, Shah ND, May CR, et al. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice [J]. J Clin Epidemiol, 2012, 65(10): 1041-1051.
[1] 何雪威, 谷美玉, 吴亭亭. 超声子宫动脉及子宫内膜血流参数对不明原因复发性流产患者妊娠结局的影响[J]. 中华医学超声杂志(电子版), 2023, 20(11): 1158-1163.
[2] 杨皓媛, 龚杰, 邹青伟, 阮航. 哮喘孕妇的母婴不良妊娠结局研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 522-529.
[3] 黎倩, 何静, 李燕玲, 罗业涛, 徐婷, 吴敏, 王羚入. 卒中后吞咽障碍患者卒中相关性肺炎预测模型的构建[J]. 中华肺部疾病杂志(电子版), 2023, 16(06): 793-798.
[4] 李莉, 向丽丽, 庹菲. 心脏超声参数对AECOPD呼吸衰竭机械通气撤机及预后的关系[J]. 中华肺部疾病杂志(电子版), 2023, 16(06): 799-803.
[5] 尚慧娟, 袁晓冬. 机械取栓术后应用依达拉奉右崁醇对急性缺血性脑卒中预后的改善[J]. 中华神经创伤外科电子杂志, 2023, 09(05): 295-301.
[6] 马良飞, 尹翎, 方婷, 曾西西, 佟佳璇, 马献昆. 重复经颅磁刺激联合虚拟现实技术对脑卒中后认知障碍的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(06): 346-351.
[7] 李旺俊, 王云霞. 抽吸联合支架取栓对超时间窗后循环缺血性脑卒中患者脑血灌注的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(06): 352-357.
[8] 廖家权, 吴波, 唐昌敏. 体外冲击波联合肌电生物反馈对脑卒中后足下垂的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 286-292.
[9] 张郁妍, 胡滨, 张伟红, 徐楣, 朱慧, 羊馨玥, 刘海玲. 妊娠中期心血管超声参数与肝功能的相关性及对不良妊娠结局的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 499-504.
[10] 沈洁, 赵弘轶, 黄勇华. 光生物调节技术在脑卒中治疗中的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(06): 613-616.
[11] 杨海华, 袁景林, 周晓梅, 陈娜, 牛军伟. 以局部麻醉为首要麻醉模式在急性前循环缺血性脑血管病机械取栓术中的有效性及安全性[J]. 中华脑血管病杂志(电子版), 2023, 17(06): 565-570.
[12] 朱敏, 李法强. 血清GFAP、UCH-L1联合VILIP-1水平对急性脑梗死神经功能预后不良的预测研究[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 452-457.
[13] 孙畅, 赵世刚, 白文婷. 脑卒中后认知障碍与内分泌激素变化的关系[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 471-476.
[14] 张许平, 刘佳成, 张舸, 杜艳姣, 李韶, 商丹丹, 王浩, 李艳, 段智慧. CYP2C19基因多态性联合血栓弹力图指导大动脉粥样硬化型非致残性缺血性脑血管事件患者抗血小板治疗的效果[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 477-481.
[15] 杨海华, 袁景林, 周晓梅, 牛军伟. RNF213基因突变所致烟雾病一家系病例临床分析并文献复习[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 495-498.
阅读次数
全文


摘要